Serum cholesteryl ester transfer protein concentrations are associated with serum levels of total cholesterol, beta-lipoprotein and apoproteins in patients with type 2 diabetes mellitus

Medical Principles and Practice

Volumn 16, Issue 5, 2007, Pages 367-372

  Inukai, Y ^a   Ito, K ^a   Hara, K ^a   Yamazaki, A ^a   Takebayashi, K ^a   Aso, Y ^a   Inukai, T ^a  

^a DOKKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Lipoprotein; Apoprotein; Cholesterol; Cholesteryl ester transfer protein; Diabetes mellitus

Indexed keywords

APOPROTEIN; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN METABOLISM;

APOPROTEINS; CASE-CONTROL STUDIES; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEINS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; JAPAN; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; SEX FACTORS; STATISTICS AS TOPIC;

EID: 34548063192     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000104810     Document Type: Article

References (32)

1. Kahri J, Groop PH, Elliott T, Viberti G, Taskinen MR: Plasma cholesteryl ester transfer protein and its relationship to plasma lipoproteins and apolipoprotein A-I-containing lipoproteins in IDDM patients with microalbuminuria and clinical nephropathy. Diabetes Care 1994;17:412-419.
2. Riemens SC, van Tol A, Stulp BK, Dullaart RPF: Influence of insulin sensitivity and Taq1B cholesteryl ester transfer protein gene polymorphism on plasma lecithin: cholesterol acyltransferase and lipid transfer protein activities and their response to hyperinsulinemia in non-diabetic men. J Lipid Res 1999;40:1467-1474.
3. Erkelens DW: Diabetic dyslipidaemia. Eur Heart J 1998;19(suppl):H27-H40.
4. Riemens SC, van Tol A, Sluiter WJ, Dullaart RP: Plasma phospholipid transfer protein activity is lowered by 24-hour insulin and acipimox administration: blunted response to insulin in type 2 diabetic patients. Diabetes 1999;48:1631-1637.
5. Jones RJ, Owens D, Brennan C, Collins PB, Johnson AH, Tomkin GH: Increased esterification of cholesterol and transfer of cholesteryl ester to apo B-containing lipoproteins in type 2 diabetes: relationship to serum lipoproteins A-I and A-II. Atherosclerosis 1996;119:151-157.
6. Inazu A, Brown ML, Hesler CB, Agellon LB, Koizumi J, Takata K, Maruhama Y, Mabuchi H, Tall AR: Increased high density lipoprotein levels caused by a common cholesteryl ester transfer protein gene mutation. N Engl J Med 1990;323:1234-1238.
7. Dullaart RP, Hoogenberg K, Riemens SC, Groener JE, van Tol A, Sluiter WJ, Stulp BK: Cholesteryl ester transfer protein gene polymorphism is a determinant of HDL cholesterol and of the lipoprotein response to a lipid-lowering diet in type 1 diabetes. Diabetes 1997;46:2082-2087.
8. Bernard S, Moulin P, Lagrost L, Picard S, Elchebly M, Ponsin G, Chapuis F, Berthezene F: Association between plasma HDL-cholesterol concentration and Taq1B CETP gene polymorphism in non-insulin-dependent diabetes mellitus. J Lipid Res 1998;39:59-65.
9. Durlach A, Clavel C, Girard-Globa A, Durlach V: Sex-dependent association of a genetic polymorphism of cholesteryl ester transfer protein with high-density lipoprotein cholesterol and macrovascular pathology in type II diabetic patients. J Clin Endocrinol Metab 1999;84:3656-3659.
10. Coppack SW: Postprandial lipoproteins in non-insulin-dependent diabetes mellitus. Diabet Med 1997;14(suppl 3):S67-S74.
11. Reaven GM: Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
12. Bagdade JD, Wagner JD, Rudel LL, Clarkson TB: Accelerated cholesteryl ester transfer and altered lipoprotein composition in diabetic cynomolgus monkeys. J Lipid Res 1995;36:759-766.
13. Desrumaux C, Athias A, Bessede G, Verges B, Farnier M, Persegol L, Gambert P, Lagrost L: Mass concentration of plasma phospholipid transfer protein in normolipidemic, type IIa hyperlipidemic, type IIb hyperlipidemic, and non-insulin-dependent diabetic subjects as measured by a specific ELISA. Arterioscler Thromb Vasc Biol 1999;19:266-275.
14. Tan KC, Shiu SW, Chu BY: Roles of hepatic lipase and cholesteryl ester transfer protein in determining low density lipoprotein subfraction distribution in Chinese patients with non-insulin-dependent diabetes mellitus. Atherosclerosis 1999;145:273-278.
15. Elchebly M, Porokhov B, Pulcini T, Berthezene F, Ponsin G: Alterations in composition and concentration of lipoproteins and elevated cholesteryl ester transfer in non-insulin-dependent diabetes mellitus (NIDDM). Atherosclerosis 1996;123:93-101.
16. Chang CK, Tso TK, Snook JT, Zipf WB, Lozano RA: Sandwich enzyme-linked immunosorbent assay for plasma cholesteryl ester transfer protein concentration. Clin Biochem 1999;32:257-262.
17. Mann CJ, Yen FT, Grant AM, Bihain B: Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J Clin Invest 1991;88:2059-2066.
18. Yamashita S, Hui DY, Wetterau JR, Sprecher DL, Harmony JAK, Sakai N, Matsuzawa Y, Tarui S: Characterization of plasma lipoproteins in patients heterozygous for human plasma cholesteryl ester transfer protein (CETP) deficiency. Metabolism 1991;40:756-763.
19. Kahri J, Syvanne M, Hayashibe H, Asayama K, Nakane T, Kobayashi K, Amemiya S, Nakazawa S: Decreased activity of plasma cholesteryl ester transfer protein in children and adolescents with insulin-dependent diabetes mellitus. Acta Paediatr 1999;88:1067-1070.
20. Dullaart RP, De Vries R, Scheek L, Borggreve SE, Van Gent T, Dallinga-Thie GM, Ito M, Nahgano M, Sluiter WJ, Hattori H, Van Tol A: Type 2 diabetes mellitus is associated with differential effects on plasma cholesteryl ester transfer protein and phospholipids transfer protein activities and concentrations. Scand J Clin Lab Invest 2004;64:205-215.
21. MacLean PS, Vadlamudi S, MacDonald KG, Pories WJ, Barakat HA: Suppression of hepatic cholesteryl ester transfer protein expression in obese humans with the development of type 2 diabetes mellitus. J Clin Endocrinol Metab 2005;90:2250-2258.
22. Lottenberg SA, Lottenberg AM, Nunes VS, McPherson R, Quintao EC: Plasma cholesteryl ester transfer protein concentration, high-density lipoprotein cholesterol esterification and transfer rates to lighter density lipoproteins in the fasting state and after a test meal are similar in type II diabetics and normal controls. Atherosclerosis 1996;127:81-90.
23. Bagdade JD, Kelley DE, Henry RR, Eckel RH, Ritter MC: Effects of multiple daily insulin injections and intraperitoneal insulin therapy on cholesteryl ester transfer and lipoprotein lipase activities in NIDDM. Diabetes 1997;46:414-420.
24. Riemens SC, van Tol A, Sluiter WJ, Dullaart RP: Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein. Atherosclerosis 1998;140:71-79.
25. Viberti G, Lachin J, Holman R, Zinman B, Haffner S, Kravitz B, Heise MA, Jones NP, O'Neill MC, Freed MI, Kahn SE, Herman WH;for the ADOPT Study Group. A diabetes outcome progression trial (ADOPT): baseline characteristics of type 2 diabetic patients in North America and Europe. Diabet Med 2006;23:1289-1294.
26. Sutherland WH, Walker RJ, Lewis-Barned NJ, Pratt H, Tillman HC: The effect of acute hyperinsulinemia on plasma cholesteryl ester transfer protein activity in patients with non-insulin-dependent diabetes mellitus and healthy subjects. Metabolism 1994;43:1362-1366.
27. Arii K, Suehiro T, Yamamoto M, Ito H, Hashimoto K: Suppression of plasma cholesteryl ester transfer protein activity in acute hyperinsulinemia and effect of plasma nonesterified fatty acid. Metabolism 1997;46:1166-1170.
28. Dullaart RP, Groener JE, Dikkeschei BD, Erkelens DW, Doorenbos H: Elevated cholesteryl ester transfer protein activity in IDDM men who smoke. Possible factor for unfavorable lipoprotein profile. Diabetes Care 1991;14:338-341.
29. Ukkola O, Savolainen MJ, Salmela PI, von Dickhoff K, Kesaniemi YA: DNA polymorphisms at the locus for human cholesteryl ester transfer protein (CETP) are associated with macro- and microangiopathy in noninsulin-dependent diabetes mellitus. Clin Genet 1994;46:217-227.
30. Castle CK, Kuiper SL, Blake WL, Paigen B, Marotti KR, Melchior GW: Remodeling of the HDL in NIDDM: a fundamental role for cholesteryl ester transfer protein. Am J Physiol 1998;274:E1091-E1098.
31. Durlach V, Attia N, Zahouani A, Leutenegger M, Girard-Globa A: Postprandial cholesteryl ester transfer and high density lipoprotein composition in normotriglyceridemic non-insulin-dependent diabetic patients. Atherosclerosis 1996;120:155-165.
32. Yilmaz H, Agchan B, Karaali ZE, Isbir T: Taq1B polymorphism of CETP gene on lipid abnormalities in patients with type II diabetes mellitus. Int J Mol Med 2004;13:889-893.